References
Erbes T, Orlowska-Volk M, Zur Hausen A, et al. Neoadjuvant chemotherapy in breast cancer significantly reduces number of yielded lymph nodes by axillary dissection. BMC Cancer. 2014;14:4. https://doi.org/10.1186/1471-2407-14-4.
Lee MC, Plews R, Rawal B, Kiluk JV, Loftus L, Laronga C. Factors affecting lymph node yield in patients undergoing axillary node dissection for primary breast cancer: a single-institution review. Ann Surg Oncol. 2012;19(6):1818–24. https://doi.org/10.1245/s10434-011-2199-9.
Boughey JC, Donohue JH, Jakub JW, Lohse CM, Degnim AC. Number of lymph nodes identified at axillary dissection: effect of neoadjuvant chemotherapy and other factors. Cancer. 2010;116(14):3322–9. https://doi.org/10.1002/cncr.25207.
Fan B, Romatoski K, Pardo J, et al. Evaluating axillary lymph node yield after neoadjuvant chemotherapy. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-12438-8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Ted James: Advisor for Perimeter Medical.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Fan, B., James, T.A. ASO Author Reflections: Expectations in Axillary Lymph Node Dissections After Neoadjuvant Chemotherapy. Ann Surg Oncol 30, 112–113 (2023). https://doi.org/10.1245/s10434-022-12636-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-12636-4